DIFESA CAPITAL MANAGEMENT, LP - PHOENIX BIOTECH ACQUISITION ownership

Back to all holdings Add to watchlist

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K204. A total of 4 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
DIFESA CAPITAL MANAGEMENT, LP ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$1,265,000
+0.5%
125,0000.0%0.64%
-10.3%
Q2 2022$1,259,000
+0.1%
125,0000.0%0.72%
+13.1%
Q1 2022$1,258,000
-0.2%
125,0000.0%0.64%
-25.9%
Q4 2021$1,261,000–125,000–0.86%–
 Download
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 100,000$1,031,0000.21%
FLOW TRADERS U.S. LLC 10,247$1040.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Tower Research Capital LLC (TRC) 175$20.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders